Short Interest in NeuroOne Medical Technologies Co. (NASDAQ:NMTC) Decreases By 34.4%

NeuroOne Medical Technologies Co. (NASDAQ:NMTC) was the recipient of a significant decrease in short interest in the month of March. As of March 15th, there was short interest totalling 134,000 shares, a decrease of 34.4% from the February 28th total of 204,300 shares. Based on an average daily trading volume, of 212,400 shares, the short-interest ratio is presently 0.6 days. Approximately 0.5% of the company’s stock are short sold.

NeuroOne Medical Technologies Trading Down 4.7 %

NASDAQ:NMTC traded down $0.04 during mid-day trading on Friday, hitting $0.86. The stock had a trading volume of 35,858 shares, compared to its average volume of 146,994. NeuroOne Medical Technologies has a twelve month low of $0.55 and a twelve month high of $1.39. The company has a market capitalization of $26.54 million, a PE ratio of -3.31 and a beta of 0.48. The stock has a 50-day simple moving average of $1.07 and a two-hundred day simple moving average of $0.94.

NeuroOne Medical Technologies (NASDAQ:NMTC) last announced its quarterly earnings data on Wednesday, February 12th. The company reported $0.06 earnings per share for the quarter. NeuroOne Medical Technologies had a negative net margin of 82.17% and a negative return on equity of 270.70%.

Institutional Inflows and Outflows

A number of hedge funds have recently modified their holdings of NMTC. Jane Street Group LLC purchased a new stake in NeuroOne Medical Technologies in the fourth quarter valued at $33,000. Geode Capital Management LLC raised its stake in shares of NeuroOne Medical Technologies by 9.8% during the 4th quarter. Geode Capital Management LLC now owns 311,659 shares of the company’s stock worth $257,000 after buying an additional 27,804 shares in the last quarter. Finally, XTX Topco Ltd purchased a new position in NeuroOne Medical Technologies in the third quarter worth $26,000. 16.07% of the stock is owned by hedge funds and other institutional investors.

About NeuroOne Medical Technologies

NeuroOne Medical Technologies Corporation, a developmental stage company, provides solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other related neurological disorders.